Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Johnson & Johnson to test experimental HIV vaccine in U.S., Europe

Written by: | no-reply@reuters.com | Dated: Friday, July 12th, 2019

 

(Reuters) – Johnson & Johnson said on Friday it plans to conduct a late-stage study of its investigational vaccine for Human Immunodeficiency Virus (HIV) in several countries across the Americas and Europe, including the United States.

The drugmaker already has a mid-stage HIV vaccine study underway in five southern African countries.

There are currently no vaccines for HIV, a virus that weakens the body’s immune system.

 

Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila

 

Reuters source:

https://www.reuters.com/article/us-johnson-johnson-hiv/johnson-johnson-to-test-experimental-hiv-vaccine-in-u-s-europe-idUSKCN1U720D

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom